Search results for "fol"

showing 10 items of 7082 documents

Gynecological Disorders in Patients with Non-celiac Wheat Sensitivity

2019

Background: Non-celiac wheat sensitivity (NCWS) most frequently presents clinically with irritable bowel syndrome (IBS)-like symptoms, although many extra-intestinal manifestations have also been attributed to it. No studies to date have evaluated the presence and frequency of gynecological symptoms in NCWS. Aim: To evaluate the frequency of gynecological disorders in patients with NCWS. Patients and Methods: Sixty-eight women with NCWS were included in the study. A questionnaire investigating gynecological symptoms and recurrent cystitis was administered, and patients reporting symptoms were then examined by specialists. Three control groups were selected: 52 patients with IBS not related …

Adultmedicine.medical_specialtySettore MED/09 - Medicina InternaPhysiologyNon-celiac wheat sensitivitymedia_common.quotation_subjectCystitiDiseaseWheat HypersensitivityGastroenterology03 medical and health sciencesDiet Gluten-FreeYoung Adult0302 clinical medicineInternal medicineCystitismedicineHumansIn patientGynecological disordersProspective StudiesVaginitisIrritable bowel syndromeMenstrual cycleVaginitismedia_commonbusiness.industryMenstrual cycle abnormalitieGastroenterologyHepatologyMiddle Agedmedicine.diseaseCeliac DiseaseIrritable bowel syndrome030220 oncology & carcinogenesisRecurrent cystitis030211 gastroenterology & hepatologyFemaleObstetric diseasebusinessFollow-Up Studies
researchProduct

Fluctuation of the left ventricular ejection fraction in patients with HER2-positive early breast cancer treated by 12 months of adjuvant trastuzumab.

2018

Abstract Background Cardiac toxicity with a decrease of the left ventricular ejection fraction (LVEF) is the main side effect induced by trastuzumab. This study reports the fluctuation of LVEF over the 12 months of adjuvant trastuzumab in PHARE trial (NCT00381901). Methods LVEF assessment was performed every 3 months while patients received trastuzumab and after completion of treatment over the first 2 years and then every 6 months afterwards. The fluctuations of LVEF over time were described and a logistic regression model was performed investigating associated factors to LVEF perfect recovery at baseline value. Results A total of 1631 patients who received 12 months of trastuzumab from PH…

Adultmedicine.medical_specialtySide effectReceptor ErbB-2medicine.medical_treatmentBreast Neoplasms030204 cardiovascular system & hematologyVentricular Function Left03 medical and health sciences0302 clinical medicineBreast cancerAntineoplastic Agents ImmunologicalTrastuzumabInternal medicinemedicineHumansIn patientcardiovascular diseasesCardiotoxicityEjection fractionbusiness.industryGeneral MedicineMiddle AgedTrastuzumabmedicine.diseaseCardiotoxicityStandard errorChemotherapy AdjuvantEchocardiography030220 oncology & carcinogenesiscardiovascular systemCardiologySurgeryFemalebusinessAdjuvantcirculatory and respiratory physiologymedicine.drugFollow-Up StudiesBreast (Edinburgh, Scotland)
researchProduct

Congenital dermatofibrosarcoma protuberans: 30 years of follow-up

2007

Summary Dermatofibrosarcoma protuberans (DFSP) is a rare fibrohistiocytic tumor that commonly appears in adult patients. Few cases of DFSP in childhood have been reported. We describe a case of congenital DFSP that had been incompletely excised in childhood, and again at 28 years of age. The 33-year-old woman presented with a recurrence. When comparing the histologic features of the previous specimens excised in 1970 and 30 years later, the similar typical storiform pattern of fibromatous cells was found. The small number of proliferation-marker-positive cells was not altered over the course of 30 years. In line with a few additional reports, we suggest that congenital dermatofibrosarcoma p…

Adultmedicine.medical_specialtySkin NeoplasmsAdult patientsbusiness.industryDermatofibrosarcomaDermatologyFibrohistiocytic tumormedicine.diseaseDermatologyChild PreschoolDermatofibrosarcoma protuberansmedicineHumansFemaleNeoplasm Recurrence LocalbusinessFollow-Up StudiesJDDG
researchProduct

Changes in sexual function and quality of life after single-incision mid-urethral sling for treatment of female stress urinary incontinence.

2013

Abstract Objectives To evaluate the effectiveness and assess the changes in sexual function and quality of life after placement of a single-incision sling for the treatment of female stress urinary incontinence. Study design A prospective study of women diagnosed with stress urinary incontinence. The single-incision sling was implanted and patients were followed postoperatively for 6 months. The postoperative rate of continence, complications, changes in sexual function, and patient-reported quality of life were evaluated. Female Sexual Function in sexually active patients was evaluated before and after the single-incision sling procedure using the Female Sexual Function Index. From January…

Adultmedicine.medical_specialtySling (implant)Urinary Incontinence StressUrologyUrinary incontinenceSeverity of Illness IndexPatient satisfactionPostoperative ComplicationsQuality of lifeCost of IllnessGermanySeverity of illnessMedicineHumansProspective StudiesSexual Dysfunctions PsychologicalProspective cohort studyAgedPsychiatric Status Rating ScalesSuburethral Slingsbusiness.industryObstetrics and GynecologyMiddle AgedSurgeryPostmenopauseSexual Dysfunction PhysiologicalReproductive MedicinePremenopausePatient SatisfactionQuality of LifeFemaleImplantmedicine.symptombusinessSexual functionFollow-Up StudiesEuropean journal of obstetrics, gynecology, and reproductive biology
researchProduct

Neuromuscular adaptations and serum hormones in females during prolonged power training.

1990

Training-induced adaptations in the neuromuscular and endocrine systems were investigated in seven females during prolonged power type strength training. Great (p less than 0.05) changes occurred primarily during the earlier weeks of the 16-week training especially in the time of force production (from 161 +/- 107 to 93 +/- 65 ms to produce a 500 N force) and, correspondingly, in the average forces in the earlier positions of the (absolute) force-time curve of the leg extensor muscles. These changes were accompanied by significant (p less than 0.05) increases in the neural activation of the trained muscles in the earliest positions of the IEMG-time curve. Hypertrophic changes, as judged fro…

Adultmedicine.medical_specialtyStrength trainingBiopsyPhysical ExertionNeuromuscular JunctionPhysical Therapy Sports Therapy and RehabilitationElectromyographyMuscle hypertrophyFollicle-stimulating hormoneSex hormone-binding globulinInternal medicineEndocrine GlandsmedicineHumansOrthopedics and Sports MedicineTestosteronePhysical Education and Trainingbiologymedicine.diagnostic_testbusiness.industryElectromyographyMusclesHypertrophyAdaptation PhysiologicalHormonesEndocrinologybiology.proteinFemaleLuteinizing hormonebusinessHormoneInternational journal of sports medicine
researchProduct

Subepithelial connective tissue graft with or without enamel matrix derivative for the treatment of Miller class I and II gingival recessions: a cont…

2012

Background The aim of this study was to evaluate whether the combination of enamel matrix derivative (EMD) with subepithelial connective tissue graft (SCTG) plus coronally advanced flap (CAF) would improve the treatment outcomes of Miller class I and II gingival recessions when compared with the same technique (SCTG plus CAF) alone. Methods The study was designed as a randomized, parallel, controlled, double-blinded clinical trial. Forty-two patients were randomly assigned in the test group (SCTG plus EMD) and in the control group (SCTG). Patients had at least one gingival recession ≥ 2 mm. The clinical parameters were evaluated at baseline and at 14 d, 1, 3, 6 and 12 mo follow-up time poin…

Adultmedicine.medical_specialtyTest groupTreatment outcomeGingivaDentistrySubepithelial connective tissue graftEsthetics DentalSurgical FlapsRoot Planinglaw.inventionYoung AdultDental Enamel ProteinsDouble-Blind MethodRandomized controlled triallawEnamel matrix derivativemedicineHumansPeriodontal PocketGingival RecessionTooth RootGingival recessionbusiness.industryMean ageMiddle AgedSurgeryTreatment OutcomeConnective TissuePhotography DentalKeratinsPeriodonticsmedicine.symptombusinessAfter treatmentFollow-Up StudiesJournal of Periodontal Research
researchProduct

THE OPTIMIZATION OF INTERFERON FOR MS STUDY: 375 MICROG INTERFERON BETA-1B IN SUBOPTIMAL RESPONDERS.

2008

We aimed to evaluate the safety and MRI efficacy of interferon beta-1b (IFNbeta-1b) 375 microg (subcutaneously [sc] every other day [eod]) in relapsing-remitting multiple sclerosis (RRMS) patients with a suboptimal response to IFNbeta-1b 250 microg, i.e., with MRI activity or relapses. The OPTimization of Interferon for MS (OPTIMS) study was a prospective multicenter randomized phase 2 trial comprising a 6-month run-in phase (to identify suboptimal responders) and a 6-month randomized phase of open-label clinical and blinded MRI follow-up. During run-in all patients were treated with IFNbeta-1b 250 microg sc eod; during the study phase suboptimal treatment responders were randomized either …

Adultmedicine.medical_specialtyTime FactorsAdolescentInjections Subcutaneoussuboptimal treatment responseGastroenterologyDrug Administration Schedulelaw.inventionYoung AdultMultiple Sclerosis Relapsing-RemittingAdjuvants ImmunologicRandomized controlled triallawInternal medicinemedicineHumansSingle-Blind MethodProspective StudiesAdverse effectProspective cohort studyinterferon beta (IFNβ)immunomodulatory drugSubclinical infectionDose-Response Relationship Drugbusiness.industryInterferon beta-1bInterferon-betaMiddle AgedMagnetic Resonance ImagingConfidence intervalSurgeryClinical trialTreatment OutcomeNeurologyRelative riskmultiple sclerosiMRI activitySettore MED/26 - NeurologiaNeurology (clinical)businessFollow-Up StudiesInterferon beta-1b
researchProduct

Vitamin metabolism in patients with a Mainz pouch I: long-term followup.

1997

We assessed whether creation of the Mainz pouch I, which requires 24 to 36 cm. of terminal ileum and 12 cm. of ascending colon including the ileocecal valve, leads to metabolic disturbances.In 137 patients the levels of vitamins A, B1, B2, B6, B12, D and E, folic and bile acids, ammonia, and intracorpuscular vitamin B12 and folic acid were evaluated and a red blood count was performed. Patients were divided into children and adults, and into 3 groups according to number of years after surgery (2 or less, more than 2 to 4 and more than 4).In all patients the levels of vitamins A, B1, B2, B6, D and E, folic and bile acids, and ammonia as well as red blood count were within normal ranges. In t…

Adultmedicine.medical_specialtyTime FactorsColonUrologyIleumUrineGastroenterologyIleocecal valveIleumInternal medicinemedicineAscending colonHumansVitamin B12Prospective StudiesChildbusiness.industryUrinary Reservoirs ContinentVitaminsHydroxocobalaminmedicine.anatomical_structureEndocrinologyPouchComplicationbusinessmedicine.drugFollow-Up StudiesThe Journal of urology
researchProduct

Treating Cockroach Phobia With Augmented Reality

2009

In vivo exposure is the recommended treatment of choice for specific phobias; however, it demonstrates a high attrition rate and is not effective in all instances. The use of virtual reality (VR) has improved the acceptance of exposure treatments to some individuals. Augmented reality (AR) is a variation of VR wherein the user sees the real world augmented by virtual elements. The present study tests an AR system in the short (posttreatment) and long term (3, 6, and 12 months) for the treatment of cockroach phobia using a multiple baseline design across individuals (with 6 participants). The AR exposure therapy was applied using the "one-session treatment" guidelines developed by Öst, Salko…

Adultmedicine.medical_specialtyTime FactorsPsychotherapistmedicine.medical_treatmentExposure therapyCockroachesVirtual realityUser-Computer InterfaceYoung AdultPhysical medicine and rehabilitationSurveys and Questionnairesbiology.animalmedicineAnimalsHumansPsychiatric Status Rating ScalesCockroachAr systembiologymedicine.diseaseClinical PsychologyTreatment OutcomeMultiple baseline designPhobic DisordersFemaleAugmented realityPsychologyAfter treatmentAnxiety disorderFollow-Up StudiesBehavior Therapy
researchProduct

TUR and Adjuvant Intravesical Chemotherapy in T1G3 Bladder Tumors: Recurrence, Progression and Survival in 137 Selected Patients Followed Up to 20 Ye…

2003

Abstract OBJECTIVES: To evaluate a highly selected population of patients affected by T1G3 bladder transitional cell carcinoma (TCCB) treated by transurethral resection (TUR) and adjuvant intravesical chemotherapy. MATERIALS AND METHODS: Between January 1976 and April 1999, 137 patients with T1G3 TCCB were treated by TUR plus intravesical chemotherapy. Particularly, a sequential combination of mitomycin C (MMC) and epirubicin (EPI) was adopted in 91 patients (66.4%). The main exclusion criteria were concomitant or previous Tis, previous T1G3 TCCB, tumor size greater than 3 centimeters and number of tumors more than 3. TUR was repeated if a superficial tumor recurred. Patients went off study…

Adultmedicine.medical_specialtyTime FactorsUrologyPopulationUrologyIntravesical adjuvant chemotherapyDisease-Free SurvivalSettore MED/24 - UrologiaT1G3 bladder cancermedicineAdjuvant therapyHumanseducationSurvival rateAgedNeoplasm StagingAged 80 and overCarcinoma Transitional Celleducation.field_of_studyUrinary bladderBladder cancerbusiness.industryMiddle Agedmedicine.diseaseSurgerySurvival Ratemedicine.anatomical_structureUrinary Bladder NeoplasmsChemotherapy AdjuvantTumor progressionConcomitantDisease ProgressionUrologic Surgical ProceduresNeoplasm Recurrence LocalbusinessConservative treatmentFollow-Up StudiesEpirubicinmedicine.drugEuropean Urology
researchProduct